Mental wellness

Mental wellness

In a previous article, we highlighted the essential role of DHA during pregnancy and its importance  in supporting the normal infant development. This essential polyunsaturated fatty acid remains just as important afterbirth, contributing to healthy growth and cognitive development throughout childhood. Insufficient DHA intake has been associated with learning difficulties and may also be involved in attention-related challenges. In adults as well, DHA promotes cognitive ability and concentration and appears to have a positive impact on mental health.

Children’s development and learning

DHA plays a role in membrane fluidity and neurotransmitter release in nervous tissue, particularly in the brain, where it is the most abundant polyunsaturated fatty acid (PUFA), accounting for 15-20% of total fatty acids in the frontal areas involved in learning, behaviour and personality.

Research indicates that DHA supplementation has an effect on children’s psychosocial functioning, emotional balance and ability to maintain focused attention. Omega-3 intake has been shown to correlate with certain cognitive test scores, especially in girls (1), and studies report measurable changes in brain activity during sustained-attention tasks following DHA concentration (2). Evidence from animals also suggests that insufficient DHA during growth and maturation may influence  brain function in adulthood (3) .

It is those with the lowest intake who benefit the most from supplementation. In a study conducted in England, daily supplementation with 600 mg of DHA  improved reading performance in 224 children whose initial scores were among the lowest 20%, with an even greater improvement observed in those within the lowest 10% (4). Additional studies suggest that higher DHA intake may support healthier sleep patterns in children, which in turn can aid with learning capacity (5,6).

Effects of DHA on reading change

Attention deficit and hyperactivity disorders (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD) is a complex condition with multiple potential contributing factors,  varied symptoms and heterogeneous responses to treatment. Standard care for young people typically combines pharmacological (i.e. drug based) and psychological interventions, while interest has grown in complementary, non-pharmacological strategies such as omega-3 supplementation for for their potential role as alternative or additive approaches (7). DHA is present in the brain at levels several hundred times higher than EPA and plays a key role in brain functions, making it a relevant candidate for research into ADHD management (8) .

A  meta-analysis by Chang et al. (9), which reviewed 7 studies involving a total of 534 young people with ADHD, reported that PUFA supplementation may support improvements in  both clinical symptoms and cognitive performance in children and teenagers.

In addition,  a 6-month study involving 50 participants aged 7 to 14 years showed that DHA supplementation was associated with improvements in psychosocial functioning, emotional difficulties and focused attention, with differences between the DHA and placebo groups, becoming apparent after just 3 months(7).

DHA supplementation improves circulating DHA and EPA

While the human body can convert dietary Eicosapentaenoic acid (EPA)t into DHA,  the reverse does not occur. Studies have consistently shown that supplementing with DHA raises the circulating levels of both DHA and EPA.(10,11). This effect is likely due to a reduced need for the body to convert dietary EPA into DHA (12). Therefore, increasing DHA intake through  supplementation can support the balance of these essential fatty acids, which play complementary roles in maintaining  overall health.

Mental Wellness

Depression and anxiety are among the most prevalent mental health disorders, affecting over 10% of the population and accounting for over 10% of the global disease burden. According to the WHO, major depression has historically been the leading cause of disability worldwide (13). Despite the availability of numerous medications prescribed for depression, 19% to 34% of patients don’t respond to first-line treatments (8). Other illnesses such as schizophrenia, bipolar disorder and eating disorders, can also have significant long-term impacts on wellbeing.

Nutrition plays a key role in mental wellbeing. Research has shown correlations between national rates of depression and apparent fish consumption (14), although cultural, economic and social factors influence outcomes. Beyond conventional  treatments, clinical studies increasingly explore how nutritional supplementation, including polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotics, can help preserve mental wellness (8).

Many studies have noted the low DHA levels in brain or blood of individuals with depression or anxiety (15, 16). Current evidence suggests that omega-3 supplementation can have a positive impact on progression or severity of mental disorders across all age groups, from children and adolescents (17) , adults (8) and the over-60s (18) .

Regular DHA supplementation, from childhood to senior age, has the potential to improve mental function, improving attention and learning performance. It may also positively  impact overall mental health and quality of life.

While many of these benefits are attributed to  DHA’s role in the membranes of nervous tissues, especially in the brain, studies  indicates that some effects may also stem from its influence on the gut microbiota,  microorganisms that play a more significant role in our health than previously recognized.

We will explore how DHA shapes gut microbiota and the implications this has for mental and overall  health.

Bibliopraphy :

1. Lassek, W. D. & Gaulin, S. J. C. Sex differences in the relationship of dietary Fatty acids to cognitive measures in american children. Front. Evol. Neurosci. 3, 5 (2011).

2. McNamara, R. K. et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am. J. Clin. Nutr. 91, 1060–1067 (2010).

3. Bhatia, H. S. et al. Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PloS One 6, e28451 (2011).

4. Richardson, A. J., Burton, J. R., Sewell, R. P., Spreckelsen, T. F. & Montgomery, P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PloS One 7, e43909 (2012).

5. Montgomery, P., Burton, J. R., Sewell, R. P., Spreckelsen, T. F. & Richardson, A. J. Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study–a randomized controlled trial. J. Sleep Res. 23, 364–388 (2014).

6. Tang, J., Yan, Y., Zheng, J.-S., Mi, J. & Li, D. Association between Erythrocyte Membrane Phospholipid Fatty Acids and Sleep Disturbance in Chinese Children and Adolescents. Nutrients 10, E344 (2018).

7. Rodríguez, C. et al. Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Neuropsychiatr. Dis. Treat. 15, 1193–1209 (2019).

8. Firth, J. et al. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry Off. J. World Psychiatr. Assoc. WPA 18, 308–324 (2019).

9. Chang, J. P.-C., Su, K.-P., Mondelli, V. & Pariante, C. M. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology 43, 534–545 (2018).

10. Conquer, J. A. & Holub, B. J. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J. Nutr. 126, 3032–3039 (1996).

11. Schuchardt, J. P. et al. Effects of docosahexaenoic acid supplementation on PUFA levels in red blood cells and plasma. Prostaglandins Leukot. Essent. Fatty Acids 115, 12–23 (2016).

12. Metherel, A. H., Irfan, M., Klingel, S. L., Mutch, D. M. & Bazinet, R. P. Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial. Am. J. Clin. Nutr. 110, 823–831 (2019).

13. Murray, C. J. L., Lopez, A. D., Organization, W. H., Bank, W. & Health, H. S. of P. The Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 : summary. (World Health Organization, 1996).

14. Hibbeln, J. R. Fish consumption and major depression. Lancet Lond. Engl. 351, 1213 (1998).

15. Ross, B. M. Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot. Essent. Fatty Acids 81, 309–312 (2009).

16. Lin, P.-Y., Huang, S.-Y. & Su, K.-P. A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression. Biol. Psychiatry 68, 140–147 (2010).

17. Bozzatello, P., Blua, C., Rocca, P. & Bellino, S. Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids. Biomedicines 9, 850 (2021).

18. Bai, Z.-G., Bo, A., Wu, S.-J., Gai, Q.-Y. & Chi, I. Omega-3 polyunsaturated fatty acids and reduction of depressive symptoms in older adults: A systematic review and meta-analysis. J. Affect. Disord. 241, 241–248 (2018).

En savoir plus

Let's stay in touch!

Contact Us